The Effect of a 160-Kilometer Competitive Endurance Ride on Inflammatory Marker mRNA Expression in Horses.
Authors: Page Allen E, Stewart John C, Fielding C Langdon, Horohov David W
Journal: Journal of equine veterinary science
Summary
# Editorial Summary: Inflammatory Response During 160-Kilometre Endurance Competition Competitive endurance riding pushes horses to their physiological limits, yet little has been understood about how inflammatory markers fluctuate during rather than merely after extreme exertion. Researchers collected blood samples from 77 horses competing in the Tevis Cup before the start, at 55 km and 110 km checkpoints, and immediately post-race (160 km) to measure mRNA expression of ten key inflammatory genes including cytokines (IL-1β, IL-6, IL-8, TNF-α), anti-inflammatory markers (IL-10), and immune-related genes (CD14, TLR4, MMP-1, ALOX5AP, TNFSF13B). Surprisingly, no consistent inflammatory gene expression pattern distinguished horses that completed the ride from those that failed to finish, though dramatic intra-ride dynamics emerged: most markers surged sharply at the 55 km point, with some remaining elevated and others declining toward baseline by race end. These transient but pronounced changes would be completely missed by pre- and post-ride sampling alone, meaning previous research assessing only start and finish data may have overlooked critical inflammatory windows relevant to metabolic stress and systemic fatigue. For practitioners monitoring endurance performance, checkpoint blood work should include molecular markers alongside conventional clinicopathologic parameters to capture the dynamic inflammatory trajectory that may inform intervention timing and recovery protocols.
Read the full abstract on PubMed
Practical Takeaways
- •Finishing versus non-finishing endurance horses show similar overall inflammatory responses, suggesting completion failure is not primarily driven by inflammatory marker dysregulation
- •Inflammatory markers peak early in long-distance rides (55 km), so sampling strategies for endurance horses should include early checkpoints to detect transient changes
- •Single time-point sampling may miss important intraride inflammatory dynamics; veterinarians monitoring endurance horses should collect blood at multiple checkpoints when possible to get a complete picture of metabolic stress
Key Findings
- •No significant overall differences in inflammatory marker mRNA expression between horses that completed versus failed to complete the 160 km ride
- •Profound initial increase in inflammatory marker expression at 55 km checkpoint, with markers either remaining elevated or declining toward baseline thereafter
- •Time-point-specific and group-specific differences in mRNA expression patterns were identified that would have been missed without intraride sampling
- •Markers measured included ALOX5AP, CD14, IL-10, IL-1β, IL-6, IL-8, MMP-1, TLR4, TNFα, and TNFSF13B collected at baseline, 55 km, 110 km, and 160 km